Skip to main content

Table 3 Characteristics of the 108 pairwise meta-analyses and 34 network meta-analyses. Values are median (range) [number of pairwise meta-analyses or network meta-analyses] unless stated otherwise

From: How robust are findings of pairwise and network meta-analysis in the presence of missing participant outcome data?

Characteristic

PMA

NMA

Number of studies

4 (3 to 25)

14 (4 to 104)

Randomised sample

60 (4 to 1996)

247 (12 to 18201)

Number of interventions

2

6 (3 to 22)

Observed comparisons (%)

1

42 (13 to 100a)

Εvent frequency (%) in study-arms (binary outcomes only)

47 (26 to 67)b

60 (42 to 76)b

Studies with at least one zero-cell (binary outcomes only)

2 (1 to 6) [33]

1 (1 to 4)[9]

Intervention-comparison type:

  

 Pharma versus placeboc

37 (34)

23 (68)

 Pharma versus pharmac

46 (43)

9 (26)

 Non-pharmad versus pharmac

3 (3)

1 (3)

 Non-pharma versus non-pharmac

22 (20)

1 (3)

Proportion of studies associated with:

  

 Low risk of bias due to MODe

33 (8 to 100) [6]f

50 (6 to 100) [3]f

 Moderate risk of bias due to MODe

33 (10 to 100) [2]f

44 (7 to 92)

 High risk of bias due to MODe

55 (11 to 100) [9]f

28 (4 to 80)

  1. MOD missing participant outcome data, NMA network meta-analysis, pharma pharmacological interventions, PMA pairwise meta-analysis
  2. aTwo networks on the continuous outcome are closed triangles
  3. bValues are median (interquartile range). The range of event frequency (%) in study-arms was 0 to 100 in pairwise meta-analyses and network meta-analyses
  4. cValues are numbers (percentages)
  5. dNon-pharmacological interventions include medical devices, surgical, complex, resources and infrastructure, behavioural, psychological, physical, complementary, educational, radiotherapy, vaccines, cellular and gene and screening [32]
  6. eFollowing the classification by Sackett et al. [24]: a proportion of missing participants up to 5% implies a low risk of bias due to MOD, more than 5% and up to 20% indicates a moderate risk of bias due to MOD, and more than 20% indicates a high risk of bias due to MOD
  7. fNumber of PMAs/NMAs that include only studies with a specific risk of bias due to MOD